- call +1-201-465-4211
- email sales@mrinsights.biz
Morphine is a pain medication of the opiate family which is found naturally in a number of plants and animals.
Scope of the Report:
As per the International Narcotics Control Board, 92 % of the worlds morphine is consumed by 17% of the worlds population, while the rest of the world population consumes around 8% of morphine.
The growth of the market for is driven by factors such as lifestyle changes that lead to pain and growth in number of surgical procedures as the drug is prescribed for pain relief post-surgery.
However, the addictive nature of the drug restricts the growth of the global morphine market.
The worldwide market for Morphine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Morphine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Sanofi Winthrop Industrie
Macfarlan Smith
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral Tablets
Injection
Capsule
Others
Market Segment by Applications, can be divided into
Anesthesia
Cough Suppressant
Diarrhea Suppressant
There are 15 Chapters to deeply display the global Morphine market.
Chapter 1, to describe Morphine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Morphine, with sales, revenue, and price of Morphine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Morphine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Morphine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Morphine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Morphine Introduction
1.2 Market Analysis by Type
1.2.1 Oral Tablets
1.2.2 Injection
1.2.3 Capsule
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Anesthesia
1.3.2 Cough Suppressant
1.3.3 Diarrhea Suppressant
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mallinckrodt Pharmaceuticals
2.1.1 Business Overview
2.1.2 Morphine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mallinckrodt Pharmaceuticals Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alcaliber
2.2.1 Business Overview
2.2.2 Morphine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alcaliber Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Purdue Pharma
2.3.1 Business Overview
2.3.2 Morphine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Purdue Pharma Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi Winthrop Industrie
2.4.1 Business Overview
2.4.2 Morphine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Winthrop Industrie Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Macfarlan Smith
2.5.1 Business Overview
2.5.2 Morphine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Macfarlan Smith Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sun Pharmaceutical Industries
2.6.1 Business Overview
2.6.2 Morphine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sun Pharmaceutical Industries Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Qinghai Pharmaceutical
2.7.1 Business Overview
2.7.2 Morphine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Qinghai Pharmaceutical Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Northeast Pharmaceutical Group
2.8.1 Business Overview
2.8.2 Morphine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Northeast Pharmaceutical Group Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Morphine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Morphine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Morphine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Morphine Manufacturer Market Share in 2017
3.3.2 Top 6 Morphine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Morphine Market Analysis by Regions
4.1 Global Morphine Sales, Revenue and Market Share by Regions
4.1.1 Global Morphine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Morphine Revenue and Market Share by Regions (2013-2018)
4.2 North America Morphine Sales and Growth Rate (2013-2018)
4.3 Europe Morphine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Morphine Sales and Growth Rate (2013-2018)
4.5 South America Morphine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Morphine Sales and Growth Rate (2013-2018)
5 North America Morphine by Countries
5.1 North America Morphine Sales, Revenue and Market Share by Countries
5.1.1 North America Morphine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Morphine Revenue and Market Share by Countries (2013-2018)
5.2 United States Morphine Sales and Growth Rate (2013-2018)
5.3 Canada Morphine Sales and Growth Rate (2013-2018)
5.4 Mexico Morphine Sales and Growth Rate (2013-2018)
6 Europe Morphine by Countries
6.1 Europe Morphine Sales, Revenue and Market Share by Countries
6.1.1 Europe Morphine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Morphine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Morphine Sales and Growth Rate (2013-2018)
6.3 UK Morphine Sales and Growth Rate (2013-2018)
6.4 France Morphine Sales and Growth Rate (2013-2018)
6.5 Russia Morphine Sales and Growth Rate (2013-2018)
6.6 Italy Morphine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Morphine by Countries
7.1 Asia-Pacific Morphine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Morphine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Morphine Revenue and Market Share by Countries (2013-2018)
7.2 China Morphine Sales and Growth Rate (2013-2018)
7.3 Japan Morphine Sales and Growth Rate (2013-2018)
7.4 Korea Morphine Sales and Growth Rate (2013-2018)
7.5 India Morphine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Morphine Sales and Growth Rate (2013-2018)
8 South America Morphine by Countries
8.1 South America Morphine Sales, Revenue and Market Share by Countries
8.1.1 South America Morphine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Morphine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Morphine Sales and Growth Rate (2013-2018)
8.3 Argentina Morphine Sales and Growth Rate (2013-2018)
8.4 Colombia Morphine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Morphine by Countries
9.1 Middle East and Africa Morphine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Morphine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Morphine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Morphine Sales and Growth Rate (2013-2018)
9.3 UAE Morphine Sales and Growth Rate (2013-2018)
9.4 Egypt Morphine Sales and Growth Rate (2013-2018)
9.5 Nigeria Morphine Sales and Growth Rate (2013-2018)
9.6 South Africa Morphine Sales and Growth Rate (2013-2018)
10 Global Morphine Market Segment by Type
10.1 Global Morphine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Morphine Sales and Market Share by Type (2013-2018)
10.1.2 Global Morphine Revenue and Market Share by Type (2013-2018)
10.2 Oral Tablets Sales Growth and Price
10.2.1 Global Oral Tablets Sales Growth (2013-2018)
10.2.2 Global Oral Tablets Price (2013-2018)
10.3 Injection Sales Growth and Price
10.3.1 Global Injection Sales Growth (2013-2018)
10.3.2 Global Injection Price (2013-2018)
10.4 Capsule Sales Growth and Price
10.4.1 Global Capsule Sales Growth (2013-2018)
10.4.2 Global Capsule Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Morphine Market Segment by Application
11.1 Global Morphine Sales Market Share by Application (2013-2018)
11.2 Anesthesia Sales Growth (2013-2018)
11.3 Cough Suppressant Sales Growth (2013-2018)
11.4 Diarrhea Suppressant Sales Growth (2013-2018)
12 Morphine Market Forecast (2018-2023)
12.1 Global Morphine Sales, Revenue and Growth Rate (2018-2023)
12.2 Morphine Market Forecast by Regions (2018-2023)
12.2.1 North America Morphine Market Forecast (2018-2023)
12.2.2 Europe Morphine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Morphine Market Forecast (2018-2023)
12.2.4 South America Morphine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Morphine Market Forecast (2018-2023)
12.3 Morphine Market Forecast by Type (2018-2023)
12.3.1 Global Morphine Sales Forecast by Type (2018-2023)
12.3.2 Global Morphine Market Share Forecast by Type (2018-2023)
12.4 Morphine Market Forecast by Application (2018-2023)
12.4.1 Global Morphine Sales Forecast by Application (2018-2023)
12.4.2 Global Morphine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Morphine Picture
Table Product Specifications of Morphine
Figure Global Sales Market Share of Morphine by Types in 2017
Table Morphine Types for Major M
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
